Plasma neurofilament L to amyloid β42 ratio in differentiating Alzheimer’s type from non-Alzheimer’s dementia: A cross-sectional pilot study from India-Reference-Cited by-同舟云学术

Plasma neurofilament L to amyloid β42 ratio in differentiating Alzheimer’s type from non-Alzheimer’s dementia: A cross-sectional pilot study from India

Published:2021-12 Issue: Volume:66 Page:102914
ISSN:1876-2018
Container-title:Asian Journal of Psychiatry
language:en
Short-container-title:Asian Journal of Psychiatry

Author:

Subramanian Sarada,Krishna Geethu,Sivakumar Palanimuthu T.,Dahale Ajit B.,Kumar J Susheel,Sinha Preeti,Varghese Mathew

Funder

Science and Engineering Research Board

Council of Scientific and Industrial Research, India

Publisher

Elsevier BV

Subject

Psychiatry and Mental health,General Psychology,General Medicine

Reference22 articles.

1. Alzheimers association., 2021. Alzheimer’s disease facts and figures. Alzheimer’s Dement. 17 (3) 327–406.

2. Alzheimer’s and Related Disorders Society of India (ARDSI);Dementia in India,2020

3. Significance of blood and cerebrospinal fluid biomarkers for alzheimer’s disease: sensitivity, specificity and potential for clinical use;d’Abramo;J. Pers. Med.,2020

4. Plasma amyloid concentration in Alzheimer’s disease: Performance of a high-throughput amyloid assay in distinguishing Alzheimer’s disease cases from controls;Feinkohl;J. Alzheimers Dis.,2020

5. Age but not diagnosis is the main predictor of plasma amyloid beta-protein levels;Fukumoto;Arch. Neurol.,2003

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Utility of Plasma Biomarker Panels in Differential Diagnosis of Alzheimer’s Disease;Journal of Alzheimer's Disease Reports;2024-01-09

2. Pathological (Dis)Similarities in Neuronal Exosome-Derived Synaptic and Organellar Marker Levels Between Alzheimer’s Disease and Frontotemporal Dementia;Journal of Alzheimer's Disease;2022-11-01

3. The Combination of β-Asarone and Icariin Inhibits Amyloid-β and Reverses Cognitive Deficits by Promoting Mitophagy in Models of Alzheimer’s Disease;Oxidative Medicine and Cellular Longevity;2021-11-30